©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged плацебо (сляпо лечение) при всичките 905 пациенти.
©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged 354 pacientov, ktorí reagovali na liečbu liekom Natalizumab Elan Pharma, potom prešli do druhej štúdie, v ktorej sa účinky lieku Natalizumab Elan Pharma pri udržaní reakcie na liečbu porovnávali s účinkami placeba.